Locations:
Search
Can TMS predict the potential functionality of impaired brains and steer patient treatment?
First-in-man trial demonstrates safety, promising functional response rates
Nurses’ pilot program uses teach-back method
Phase 2 clinical study supports safety and efficacy of MSC-NTFs
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
With persistence, an elusive clinical challenge is consistently tackled
Registry-based PASSION initiative aims to identify epileptogenesis biomarkers, compare therapies
Why it remains the mainstay for newly diagnosed metastases and tumors
Series demonstrates comparable results with an MRI-based decision strategy
Specialists in movement disorders, palliative care and social work join together to improve quality of life
Inhibition of DNA-PK suppresses tumor growth in preclinical models
Advertisement
Advertisement